2021
Expert review of pharmacoeconomics & outcomes research, (2021).22 1 10.1080/14737167.2021.1954505.
2021
BMJ (Clinical research ed.), (2021).374, 10.1136/bmj.n1592.
2021
medRxiv (2021). 10.1101/2021.07.09.21260272.
2021
eLife, (2021).10, 10.7554/eLife.67635.
Reflecting on Economic Evaluations in Low-and-Middle Income Countries: What Can We Do Differently?.
2021
(2021).
Organized Session: Decolonising Health Economics: Where Are We and What Will It Take?.
2021
(2021).
Organized session: Economics of Tuberculosis in Low- and Middle-Income Country Settings.
2021
(2021).
Necessity As the Mother of Invention: Locally Adapted Health Technology Assessment As a Driver of Methodological and Institutional Innovation.
2021
(2021).
Informing the future research agenda for biomedical HIV prevention technologies: identifying gaps in health economics evidence and proposing future directions.
2021
(2021).
2021
Cost effectiveness and resource allocation : C/E, (2021).19 1 10.1186/s12962-021-00293-5.
